Search…

Lates News

09/09/2025

BHP Billiton has agreed to settle the class action lawsuit brought by Australian shareholders of Samarco. BHP Billiton has agreed to pay the applicants 110 million Australian dollars, including interest and costs, without admitting any liability.

Latest

2 m ago

On September 9th, Novartis announced that it has reached an agreement to acquire the biopharmaceutical company Tourmaline. According to the terms of the deal, Novartis will launch a tender offer through its indirect wholly-owned subsidiary to acquire all outstanding common shares of Tourmaline. Shareholders of Tourmaline will receive a cash consideration of $48 per share upon completion of the transaction. Following the tender offer, Novartis plans to merge the acquired subsidiary with Tourmaline to make it an indirect wholly-owned subsidiary of Novartis.

2 m ago

Novartis announces acquisition of Tourmaline at $48 per share.

3 m ago

Two major ship information systems in the Yangtze River Basin are officially launched.

6 m ago

Production of drugs using 3D printing technology, the country's first production license landed in Nanjing.

7 m ago

Dongxing Securities: Rated "strongly recommended" for Wuliangye, with a target price of 148.5 yuan.

+852 - 60190728

Customer Support

Commercial Services